A detailed history of Financial Avengers, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Financial Avengers, Inc. holds 705 shares of ABT stock, worth $72,756. This represents 0.02% of its overall portfolio holdings.

Number of Shares
705
Previous 935 24.6%
Holding current value
$72,756
Previous $102,000 21.57%
% of portfolio
0.02%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $25,189 - $27,820
-230 Reduced 24.6%
705 $80,000
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $450 - $552
5 Added 0.54%
935 $102,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $477 - $573
5 Added 0.54%
930 $90,000
Q2 2023

Aug 04, 2023

BUY
$100.78 - $112.29 $403 - $449
4 Added 0.43%
925 $100,000
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $387 - $456
4 Added 0.44%
921 $93,000
Q4 2022

Feb 06, 2023

BUY
$95.06 - $111.52 $475 - $557
5 Added 0.55%
917 $100,000
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $290 - $336
3 Added 0.33%
912 $88,000
Q2 2022

Aug 16, 2022

SELL
$102.07 - $123.37 $8,267 - $9,992
-81 Reduced 8.18%
909 $99,000
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $21,663 - $26,417
-190 Reduced 16.1%
990 $117,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $462 - $565
4 Added 0.34%
1,180 $166,000
Q3 2021

Nov 01, 2021

SELL
$116.66 - $129.06 $57,746 - $63,884
-495 Reduced 29.62%
1,176 $139,000
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $634 - $747
6 Added 0.36%
1,671 $194,000
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $66,936 - $78,861
615 Added 58.57%
1,665 $200,000
Q4 2020

Feb 05, 2021

BUY
$105.0 - $114.42 $110,250 - $120,141
1,050 New
1,050 $115,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Financial Avengers, Inc. Portfolio

Follow Financial Avengers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Avengers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Avengers, Inc. with notifications on news.